REFERENCES
1. Espinoza JL, Kotecha R, Nakao
S. Microbe-Induced Inflammatory Signals Triggering Acquired Bone Marrow
Failure Syndromes. Front Immunol. 2017;8:186. doi:
10.3389/fimmu.2017.00186.
2. Li JP, Zheng CL, Han ZC. Abnormal immunity and stem/progenitor cells
in acquired aplastic anemia. Crit Rev Oncol Hematol.2010;75(2):79-93. doi: 10.1016/j.critrevonc.2009.12.001.
3. Fujisaki J, Wu J, Carlson AL, et al. In vivo imaging of Treg cells
providing immune privilege to the haematopoietic stem-cell niche.Nature. 2011;474(7350):216-219. doi: 10.1038/nature10160.
4. Panduro M, Benoist C, Mathis D. Tissue Tregs. Annu Rev
Immunol. 2016;34:609-633. doi: 10.1146/annurev-immunol-032712-095948.
5. Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. Immunogenetics of
autoimmune thyroid diseases: A comprehensive review. J Autoimmun.2015;64:82-90. doi: 10.1016/j.jaut.2015.07.009.
6. Speiser JJ, Mondo D, Mehta V, Marcial SA, Kini A, Hutchens KA.
Regulatory T-cells in alopecia areata. J Cutan Pathol.2019;46(9):653-658. doi: 10.1111/cup.13479.
7. Barone A, Lucarelli A, Onofrillo D, et al. Marrow Failure Study Group
of the Pediatric Haemato-Oncology Italian Association. Diagnosis and
management of acquired aplastic anemia in childhood. Guidelines from the
Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian
Association (AIEOP). Blood Cells Mol Dis. 2015;55(1):40-47. doi:
10.1016/j.bcmd.2015.03.007.
8. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to
the WHO classification of myelodysplastic and myeloproliferative
diseases. Leukemia. 2003;17(2):277-282. doi:
10.1038/sj.leu.2402765.
9. Lo Celso C, Fleming HE, Wu JW, et al. Live-animal tracking of
individual haematopoietic stem/progenitor cells in their niche.Nature. 2009;457(7225):92-96. doi: 10.1038/nature07434.
10. Hall BM, Hall RM, Tran GT, et al. Interleukin-5 (IL-5) Therapy
Prevents Allograft Rejection by Promoting
CD4+CD25+ Ts2 Regulatory Cells That
Are Antigen-Specific and Express IL-5 Receptor. Front Immunol.2021;12:714838. doi: 10.3389/fimmu.2021.714838.
11. Sakai R, Yamagami S, Inoki T, Tsuru T, Kawashima H. Th1/Th2-balance
in anterior chamber-associated immune deviation by alloantigen.Graefes Arch Clin Exp Ophthalmol. 2002;240(2):154-159. doi:
10.1007/s00417-001-0422-2.
12. Hirata Y, Furuhashi K, Ishii H, et al.
CD150high Bone Marrow Tregs Maintain Hematopoietic
Stem Cell Quiescence and Immune Privilege via Adenosine. Cell Stem
Cell. 2018;22(3):445-453.e5. doi: 10.1016/j.stem.2018.01.017.
13. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid
progenitors occupy distinct bone marrow niches. Nature.2013;495(7440):231-235. doi: 10.1016/j.stem.2018.01.017.
14. Hirata Y, Kakiuchi M, Robson SC, Fujisaki J.
CD150high CD4 T cells and
CD150high regulatory T cells regulate hematopoietic
stem cell quiescence via CD73. Haematologica.2019;104(6):1136-1142. doi: 10.3324/haematol.2018.198283.
15. Shi J, Ge M, Lu S, et al. Intrinsic impairment of
CD4+CD25+ regulatory T cells in
acquired aplastic anemia. Blood. 2012;120(8):1624-1632. doi:
10.1182/blood-2011-11-390708.
16. Li J, Lu S, Yang S, et al. Impaired immunomodulatory ability of bone
marrow mesenchymal stem cells on CD4+ T cells in
aplastic anemia. Results Immunol. 2012;2:142-147. doi:
10.1016/j.rinim.2012.07.002.
17. Dutta A, De R, Dolai TK, Mitra PK, Halder A. Changes in Different
Cytokines (IL-2, TNF-α, and IFN-γ) Profile in Acquired Aplastic Anemia
Patients: A Study From Eastern India. J Pediatr Hematol Oncol.2020;42(3):185-192. doi: 10.1097/MPH.0000000000001737.
18. Coursey TG, Chen PW, Niederkorn JY. IL-17-dependent,
IFN-gamma-independent tumor rejection is mediated by cytotoxic T
lymphocytes and occurs at extraocular sites, but is excluded from the
eye. J Immunol. 2011;187(8):4219-28. doi:
10.4049/jimmunol.1100826.
19. Kordasti S, Costantini B, Seidl T, et al. Deep phenotyping of Tregs
identifies an immune signature for idiopathic aplastic anemia and
predicts response to treatment. Blood. 2016;128(9):1193-1205.
doi: 10.1182/blood-2016-03-703702.
20. Niederkorn JY, Chen PW, Mellon J, Stevens C, Mayhew E. Allergic
conjunctivitis exacerbates corneal allograft rejection by activating Th1
and Th2 alloimmune responses. J Immunol. 2010;184(11):6076-6083.
doi: 10.4049/jimmunol.0902300.
21. Speiser JJ, Mondo D, Mehta V, Marcial SA, Kini A, Hutchens KA.
Regulatory T-cells in alopecia areata. J Cutan Pathol.2019;46(9):653-658. doi: 10.1111/cup.13479.
22. Takayama N, Murison A, Takayanagi SI, et al. The Transition from
Quiescent to Activated States in Human Hematopoietic Stem Cells Is
Governed by Dynamic 3D Genome Reorganization. Cell Stem Cell.2021;28(3):488-501.e10. doi: 10.1016/j.stem.2020.11.001.
23. Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic
anaemia. Clin Exp Immunol. 2015;180(3):361-370. doi:
10.1111/cei.12605.
24. Jiang S, Wang Y, Shi W, et al. The benefit of ATG in
immunosuppressive therapy of children with moderate aplastic anemia.Pediatr Hematol Oncol. 2009;26(5):313-320. doi:
10.1080/08880010902771549.
25. Howard SC, Naidu PE, Hu XJ, et al. Natural history of moderate
aplastic anemia in children. Pediatr Blood Cancer.2004;43(5):545-551. doi: 10.1002/pbc.20131.